Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EquiPure-FSH
- Development stage
- Unknown
- Lead developer
- AspenBio Pharma
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
EquiPure-FSH is a recombinant equine follicle-stimulating hormone (reFSH) developed for use in equine reproductive medicine. Produced using recombinant DNA technology, it consists of the alpha and beta subunits of equine FSH, providing a highly purified product that lacks the luteinizing hormone (LH) contamination typically found in pituitary-derived gonadotropin extracts. Its primary application is the induction of superovulation in mares, which is a critical component of advanced breeding and embryo transfer programs. By acting as a potent agonist at the follicle-stimulating hormone receptor (FSHR) on ovarian granulosa cells, EquiPure-FSH stimulates the recruitment and maturation of multiple follicles. This recombinant approach offers improved consistency, safety, and efficacy over traditional pituitary preparations, allowing for more precise control of the equine estrous cycle and improved reproductive outcomes.
- Brand names
- EquiPure-FSH
- Other names
- recombinant equine follicle stimulating hormonerecombinant equine FSH
02
Targets
FSHR (Follicle-stimulating hormone receptor)
Beyond the preview
Go deeper on EquiPure-FSH.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EquiPure-FSH.